» Articles » PMID: 22347626

Pentraxin 3: a Novel Biomarker for Inflammatory Cardiovascular Disease

Overview
Journal Int J Vasc Med
Publisher Wiley
Date 2012 Feb 21
PMID 22347626
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Numerous studies have recently examined the role of pentraxin 3 (PTX3) in clinical situations. The pentraxin family includes C-reactive protein (CRP); however, unlike CRP, PTX3 is expressed predominantly in atherosclerotic lesions that involve macrophages, neutrophils, dendritic cells, or smooth muscle cells. Interestingly, PTX3 gene expression in human endothelial cells is suppressed to a greater extent by pitavastatin than the expression of 6,000 other human genes that have been examined, suggesting that PTX3 may be a novel biomarker for inflammatory cardiovascular disease. The expression and involvement of PTX3 in cardiovascular diseases are discussed in this paper, along with the characteristics of PTX3 that make it a suitable biomarker; namely, that the physiological concentration is known and it is independent of other risk factors. The results discussed in this paper suggest that further investigations into the potential novel use of PTX3 as a biomarker for inflammatory cardiovascular disease should be undertaken.

Citing Articles

Involvement of pentraxin-3 in the development of hypertension but not left ventricular hypertrophy in male spontaneously hypertensive rats.

Mkhize S, Manilall A, Mokotedi L, Gunter S, Michel F Physiol Rep. 2024; 12(20):e70086.

PMID: 39414396 PMC: 11483509. DOI: 10.14814/phy2.70086.


Senescence Biomarkers CKAP4 and PTX3 Stratify Severe Kidney Disease Patients.

McCallion S, McLarnon T, Cooper E, English A, Watterson S, Chemaly M Cells. 2024; 13(19.

PMID: 39404377 PMC: 11475272. DOI: 10.3390/cells13191613.


Role of High-sensitivity C-reactive Protein in Future Cardiovascular Events in Hemodialysis Patients.

Osawa H, Nakamura N, Tsutaya C, Saitoh H, Shimada M, Murakami R In Vivo. 2024; 38(3):1351-1358.

PMID: 38688654 PMC: 11059910. DOI: 10.21873/invivo.13575.


Animal protein intake is directly associated with serum level of pentraxin 3 in hemodialysis patients.

Navab F, Foshati S, Bagherniya M, Askari G, Moeinzadeh F, Gholaminejad A Sci Rep. 2023; 13(1):21600.

PMID: 38062075 PMC: 10703852. DOI: 10.1038/s41598-023-48671-8.


Effect of Statins on the Inflammatory Markers in Patients with Coronary Artery Disease.

Premnath S, Nanda S, Ray L, Arokiaraj M J Lab Physicians. 2023; 15(4):498-502.

PMID: 37780883 PMC: 10539054. DOI: 10.1055/s-0043-1768167.


References
1.
Vasan R . Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation. 2006; 113(19):2335-62. DOI: 10.1161/CIRCULATIONAHA.104.482570. View

2.
Mauri T, Bellani G, Patroniti N, Coppadoro A, Peri G, Cuccovillo I . Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med. 2010; 36(4):621-9. DOI: 10.1007/s00134-010-1752-5. View

3.
Savchenko A, Inoue A, Ohashi R, Jiang S, Hasegawa G, Tanaka T . Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis. Pathol Int. 2011; 61(5):290-7. DOI: 10.1111/j.1440-1827.2011.02651.x. View

4.
Inoue K, Sugiyama A, Reid P, Ito Y, Miyauchi K, Mukai S . Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol. 2006; 27(1):161-7. DOI: 10.1161/01.ATV.0000252126.48375.d5. View

5.
Garlanda C, Bottazzi B, Bastone A, Mantovani A . Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol. 2005; 23:337-66. DOI: 10.1146/annurev.immunol.23.021704.115756. View